Generic Keppra Facts And Side Effects

pills Jeffrey Nadrich and The Law Offices of Nadrich & Cohen are currently reviewing potential Generic Keppra lawsuits involving consumers who have suffered breakthrough seizures after taking Generic Keppra (Levetiracetem). The Law Offices of Nadrich & Cohen are offering a free consultation to anyone who has taken Generic Keppra and suffered breakthrough seizures as a result, call us today at 1.800.718.4658. You may be eligible for compensation beyond your medical bills. We are a contingency law firm so we only charge a fee after we obtain a recovery for you. Keppra is the brand name for an anti-epileptic drug that went off patent in January 2009.  After that date, the generic form of the drug, Levetiracetam, began being substituted for Keppra.

Insurers Require Generics For Cost Savings

Costs of prescription drugs have skyrocketed over the years so it’s quite common for doctors, pharmacists and insurers to switch patients to a less expensive generic form of a prescription drug to help patients save money. Many health insurers will also require that patients only receive the generic form of a medication as a cost cutting measure. Sometimes this works and is safe and helpful to consumers. Other times depending on the medicines use it can prove to be a dangerous practice. Studies, in fact, have shown that it is unsafe to substitute a generic form like Levetiracetem for a brand name anti-epileptic drug, (AEDs) like Keppra. When it comes to AEDs, substitutions can be extremely dangerous causing breakthrough seizures, serious injury, and even death. Manufacturers of generic prescription drugs must show that their product is the “bioequivalent” of the brand name drug not necessarily an exact duplicate. “Bioequivalent” does not mean that the drug is identical.

Epilepsy Foundation Does Not Recommend Substitutions Of AEDs

Although the generic form of the brand name medication may contain the same amount of active ingredients the FDA allows a certain amount of deviation in the inactive ingredients as long as the difference and the resulting effect on the body is not deemed significant. According to the Epilepsy Foundation substitutions of AEDs is not recommended. Whether it’s switching brand name varieties to generic, or switching from generic to brand name substitutions can be dangerous because studies show that even a slight variation in the amount or delivery of the active ingredients can lead to serious injury or death in epileptic patients. If you or a loved one has taken Generic Keppra and suffered a breakthrough seizure or any side effects, contact an experienced Generic Keppra lawyer at The Law Offices of Nadrich & Cohen today at 1.800.718.4658 for a free consultation. In a three-year survey of patients who switched from brand name to generic AEDs, 59 percent of the respondents experienced worse seizures and 49 percent experienced worse side effects.

Contact Birth Defect Lawyer

At The Law Offices of Nadrich & Cohen, our Generic Keppra specialists are ready to answer all your questions. Let us help you preserve your rights, call now at 1.800.718.4658 for a free consultation and speak with a qualified Generic Keppra lawyer, click here Levetiracetem for more information.

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.


What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.


Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

March 20, 2019

Valsartan Dangers: 3 Things You Should Know

Several drugs containing Valsartan have been  recalled in the U.S. because they contain impurities which may be cancer risks. You may be eligible for financial compensation if you took a drug containing Valsartan and have been diagnosed with cancer.

March 15, 2019

Expert Testifies Before House Subcommittee Regarding Talc Use And Ovarian Cancer Link

A United States House of Representatives subcommittee, on March 12th, 2019, looked into whether they should give the Food and Drug Administration (FDA) the power to more strictly regulate cosmetics, including talcum powder and products containing talc.


We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.